Literature DB >> 19543892

Cervical transforaminal epidural steroid injection for the management of cervical radiculopathy: a comparative study of particulate versus non-particulate steroids.

Joon Woo Lee1, Kun Woo Park, Sang-Ki Chung, Jin S Yeom, Ki-Jeong Kim, Hyun-Jib Kim, Heung Sik Kang.   

Abstract

OBJECTIVE: To determine if a particulate steroid which has a risk for embolic infarct would be more effective than a non-particulate steroid for transforaminal epidural steroid injection (TFESI). The purpose of this study was (1) to compare the effect of cervical TFESI using particulate (e.g., triamcinolone) and non-particulate (e.g., dexamethasone) steroids and (2) to evaluate the effectiveness of cervical TFESI in general.
MATERIALS AND METHODS: From January 2006 to August 2008, 159 consecutive patients [male:female (M:F) 89:70; mean age 53 years, range 33-75 years] who underwent cervical TFESI were included in this non-randomized study. For cervical TFESI, triamcinolone was injected into 97 patients and dexamethasone into 62 patients. Short-term follow-up was conducted within 1 month. The outcome was classified as effective or ineffective. Fisher's exact test was used to analyze the difference of outcome according to the injected steroid (triamcinolone vs dexamethasone). Other possible outcome predictors, such as age, gender, duration of radiculopathy, predominant symptom, attack of radiculopathy, cause of radiculopathy, number of nerve root compression levels, previous operation, and failure of previous interlaminar epidural injection, were also analyzed.
RESULTS: Cervical TFESI using triamcinolone (78/97, 80.4%) was slightly more effective than that using dexamethasone (43/62, 69.4%), which was not significant (P = 0.129). In general, cervical TFESIs were effective in 121 of 159 patients (76.1%) at short-term follow-up. The only significant outcome predictor was whether the patient had had a previous operation (6/13, 46/2%) or not (115/146, 78.8%) (P = 0.015).
CONCLUSION: There was no significant difference between particulate or non-particulate steroid for the effect of cervical TFESI. Cervical TFESI was effective in managing cervical radiculopathy in general.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19543892     DOI: 10.1007/s00256-009-0735-5

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  17 in total

Review 1.  Injectable corticosteroids in modern practice.

Authors:  Brian J Cole; H Ralph Schumacher
Journal:  J Am Acad Orthop Surg       Date:  2005 Jan-Feb       Impact factor: 3.020

2.  Cervical transforaminal epidural steroid injections: should we be performing them?

Authors:  David Anthony Provenzano; Gilbert Fanciullo
Journal:  Reg Anesth Pain Med       Date:  2007 Mar-Apr       Impact factor: 6.288

3.  Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain.

Authors:  Mark V Boswell; Andrea M Trescot; Sukdeb Datta; David M Schultz; Hans C Hansen; Salahadin Abdi; Nalini Sehgal; Rinoo V Shah; Vijay Singh; Ramsin M Benyamin; Vikram B Patel; Ricardo M Buenaventura; James D Colson; Harold J Cordner; Richard S Epter; Joseph F Jasper; Elmer E Dunbar; Sairam L Atluri; Richard C Bowman; Timothy R Deer; John R Swicegood; Peter S Staats; Howard S Smith; Allen W Burton; David S Kloth; James Giordano; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2007-01       Impact factor: 4.965

4.  Therapeutic selective nerve root block in the nonsurgical treatment of atraumatic cervical spondylotic radicular pain: a retrospective analysis with independent clinical review.

Authors:  C W Slipman; J S Lipetz; H B Jackson; D P Rogers; E J Vresilovic
Journal:  Arch Phys Med Rehabil       Date:  2000-06       Impact factor: 3.966

5.  Cerebellar herniation after cervical transforaminal epidural injection.

Authors:  William A Beckman; Robert J Mendez; Gregory F Paine; Michael A Mazzilli
Journal:  Reg Anesth Pain Med       Date:  2006 May-Jun       Impact factor: 6.288

6.  Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain.

Authors:  Paul Dreyfuss; Ray Baker; Nikolai Bogduk
Journal:  Pain Med       Date:  2006 May-Jun       Impact factor: 3.750

7.  Outcome of cervical radiculopathy treated with periradicular/epidural corticosteroid injections: a prospective study with independent clinical review.

Authors:  K Bush; S Hillier
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

8.  Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990.

Authors:  K Radhakrishnan; W J Litchy; W M O'Fallon; L T Kurland
Journal:  Brain       Date:  1994-04       Impact factor: 13.501

9.  Cervical transforaminal epidural steroid injections: more dangerous than we think?

Authors:  Graham C Scanlon; Tobias Moeller-Bertram; Shawn M Romanowsky; Mark S Wallace
Journal:  Spine (Phila Pa 1976)       Date:  2007-05-15       Impact factor: 3.468

10.  Cervical interlaminar epidural steroid injection for neck pain and cervical radiculopathy: effect and prognostic factors.

Authors:  Jong Won Kwon; Joon Woo Lee; Sung Hyun Kim; Ja-Young Choi; Jin-Sup Yeom; Hyun-Jib Kim; Kyu-Sung Kwack; Sung Gyu Moon; Woo Sun Jun; Heung Sik Kang
Journal:  Skeletal Radiol       Date:  2007-03-06       Impact factor: 2.199

View more
  20 in total

Review 1.  Particulate versus non-particulate steroids for lumbar transforaminal or interlaminar epidural steroid injections: an update.

Authors:  Tobias J Dietrich; Reto Sutter; Johannes M Froehlich; Christian W A Pfirrmann
Journal:  Skeletal Radiol       Date:  2014-11-14       Impact factor: 2.199

2.  Metabolic and endocrinal effects of epidural glucocorticoid injections.

Authors:  Anuntapon Chutatape; Mahesh Menon; Stephanie Man Chung Fook-Chong; Jane Mary George
Journal:  Singapore Med J       Date:  2018-11-07       Impact factor: 1.858

3.  Reducing the risk of spinal cord infarction during transforaminal steroid injections.

Authors:  P J MacMahon; I Crosbie; E C Kavanagh
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-19       Impact factor: 3.825

4.  Pain reduction after lumbar epidural injections using particulate versus non-particulate steroids: intensity of the baseline pain matters.

Authors:  Marek Tagowski; Zbigniew Lewandowski; Jürg Hodler; Thomas Spiegel; Gerhard W Goerres
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

5.  Dystrophic calcification in the epidural and extraforaminal space caused by repetitive triamcinolone acetonide injections.

Authors:  Yong Jun Jin; Sang-Bong Chung; Ki-Jeong Kim; Hyun-Jib Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-08-31

6.  Cervical radiculopathy: a review.

Authors:  John M Caridi; Matthias Pumberger; Alexander P Hughes
Journal:  HSS J       Date:  2011-09-09

Review 7.  Particulate and non-particulate steroids in spinal epidurals: a systematic review and meta-analysis.

Authors:  I H Feeley; E F Healy; J Noel; P J Kiely; T M Murphy
Journal:  Eur Spine J       Date:  2016-02-12       Impact factor: 3.134

8.  Epidural steroid injection-related events requiring hospitalisation or emergency room visits among 52,935 procedures performed at a single centre.

Authors:  Joon Woo Lee; Eugene Lee; Guen Young Lee; Yusuhn Kang; Joong Mo Ahn; Heung Sik Kang
Journal:  Eur Radiol       Date:  2017-07-19       Impact factor: 5.315

9.  Oral prednisolone in the treatment of cervical radiculopathy: A randomized placebo controlled trial.

Authors:  Majid Ghasemi; Ali Masaeli; Majid Rezvani; Vahid Shaygannejad; Khodayar Golabchi; Rasul Norouzi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

10.  Comparative effectiveness of lumbar epidural steroid injections using particulate vs. non-particulate steroid: an intra-individual comparative study.

Authors:  Ji Young Kim; Joon Woo Lee; Geun Young Lee; Eugene Lee; Chang Jin Yoon; Heung Sik Kang
Journal:  Skeletal Radiol       Date:  2015-11-05       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.